BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for ...

Shai Biran; Investor Relations; Spero Therapeutics Inc. Esther Rajavelu; Interim President, Interim Chief Executive Officer, Chief Financial Officer, Treasurer, Chief Business Officer; Spero ...

Rhett Lowder, who was a serious candidate for the starting rotation at the start of the year, has a forearm issue, which can ...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...

The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...

Madness continues Friday with eight more games, as the men’s Sweet 16 concludes and the women’s Sweet 16 begins. The day ...

Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced that it ...

Slideshows ...

Photo shows A motorcyclist wearing a helmet and two other men bending to pick up slabs of bitumen from a large roadway crack ...